Koso Ball EX
Natural health product licensed in Canada
- Licence holder
- Umeken Canada, Inc.
- NPN or DIN-HM
- 80089036
- Status
- Active licence
- Licence date
- 5 November 2018
- Revision date
- Not provided
- Form
- Pilule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sesamum indicum Source : Graine(s) | 10.64 mg | Not calculated |
| Fibre de soja | 5.85 mg | Not calculated |
| Fibre de fruit Source : Citrus sinensis - Fruit fibre | 30.14 mg | Not calculated |
| Ipomoea batatas Source : Racine | 32.4 mg | Not calculated |
| Lactobacillus brevis Source : Cellule entière | 1.6 mg | Not calculated |
Non-medicinal ingredients
Extrait de Bidens Pilosa, Pullulane, 4-O-bêta-D-galactopyranosyl-D-glucitol, Acide citrique, Extrait de Raisin, Miel, Cire de Carnauba, Gomme-laque, Sucre, Amidon de maïs, Levure déshydratée, Poudre de cacao, Mélange de fruit et légume, Extrait de Malt, Jus d'abricot du Japon concentré, Glucose, Eau, Gomme arabique (acacia), Riz
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 8 Pilule | 1 day |
Uses authorised in Canada
Source of antioxidant(s)/Provides antioxidant(s). Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment), do not use this product.
- Précautions et mises en garde
If you have fever, vomiting, bloody diarrhoea or severe abdominal pain, consult a health care practitioner prior to use. If symptoms of digestive upset (e.g. diarrhea) occur, worsen, or persist beyond 3 days, discontinue use and consult a health care practitioner. Consult a health care practitioner prior to use if you are pregnant or breastfeeding.
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use.
Source
Official Health Canada record, licence 80089036
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.